治疗药物监测市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00003479
  • Category : Life Sciences
  • No. of Pages : 150
立即购买

治疗药物监测市场预计在 2024 年至 2031 年期间的复合年增长率为 9.0%,市场规模将从 2024 年的 XX 百万美元扩大到 2031 年的 XX 百万美元。

报告按产品(设备和消耗品)细分。报告进一步根据技术(免疫测定、色谱质谱、放射免疫测定和其他)进行了分析。报告按药物类别(抗生素药物、抗癫痫药物、抗心律失常药物、支气管扩张药物、免疫抑制药物、精神活性药物、抗癌药物和其他药物)细分。报告进一步根据最终用户(医院实验室、私人实验室和其他实验室)进行了分析。全球分析进一步细分为区域和主要国家。报告以美元为单位提供了上述分析和细分的价值。

报告目的

The Insight Partners 撰写的《治疗药物监测市场》报告旨在描述当前形势和未来增长、主要驱动因素、挑战和机遇。这将为各种业务利益相关者提供见解,例如:

  • 技术提供商/制造商:了解不断变化的市场动态并了解潜在的增长机会,从而能够做出明智的战略决策。
  • 投资者:对市场增长率、市场财务预测以及整个价值链中存在的机会进行全面的趋势分析。
  • 监管机构:监管市场政策和警察活动,旨在最大限度地减少滥用行为,维护投资者的信任和信心,维护市场的完整性和稳定性。

 

治疗药物监测市场细分

 

产品

  • 设备和耗材

技术

  • 免疫测定
  • 色谱质谱法
  • 放射免疫分析
  • 其他的

药物类别

  • 抗生素药物
  • 抗癫痫药物
  • 抗心律失常药物
  • 支气管扩张药
  • 免疫抑制药物
  • 精神活性药物
  • 抗癌药物
  • 其他药物

最终用户

  • 医院实验室
  • 私人实验室
  • 其他实验室

 

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

治疗药物监测市场:战略洞察

Therapeutic Drug Monitoring Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

 

治疗药物监测市场的增长动力

  • 慢性病患病率上升:慢性病患病率高,对药物治疗的需求相当高,对 TDM 市场产生了普遍影响。在糖尿病和高血压方面,应注意药物的精确剂量,以便在保持疗效的同时将副作用降到最低。现在,越来越多的患者接受长期药物治疗,因此接受 TDM 治疗,其中需要注意药物水平、剂量调整和预防不良反应。因此,在这方面,这个问题将鼓励医疗服务提供者引入 TDM 概念;因此,将进一步促进市场增长,并通过定制疗法实现高质量的患者护理。
  • 个性化医疗的增长:个性化医疗需求的不断增长(即根据患者的遗传和疾病状况等个人特征选择治疗方案)是 TDM 市场的主要增长动力。这种疗法在药物的疗效和安全性方面都具有诸多优势,因此 TDM 对于实时调整剂量和治疗水平至关重要。随着大多数生物制剂和靶向疗法被整合到临床环境中,对这项技术的需求将呈现上升趋势。个性化医疗的趋势正在增长,这种趋势推动医疗保健向更加个性化的形式发展,这进一步刺激了对先进 TDM 解决方案的需求,以改善与患者相关的结果。
  • 监管支持:治疗药物监测市场的监管支持基于鼓励在临床环境中采用 TDM 实践的指导方针和框架。FDA 和 EMA 等机构就特定药物(尤其是治疗指数较窄的药物)使用 TDM 提供建议。这在治疗中营造出一种安全和有效的感觉,并培养了医疗保健提供者和患者之间的信任。随着政策趋向于个性化治疗和患者保护,TDM 越来越被视为安全药物治疗的重要组成部分,这反过来又促使 TDM 在各种医疗保健系统中得到扩展和实施。

治疗药物监测市场未来趋势

  • 转向远程监控:远程监控是彻底改变治疗药物监控 (TDM) 市场的一项发展,因为它使得在传统医院和诊所环境之外进行持续护理和数据收集成为可能。COVID-19 疫情期间的情况进一步推动了这一趋势,使医疗保健提供者能够实时监控药物水平和对治疗的反应,从而提高患者的参与度和依从性。因此,由于远程监控技术的存在,不良反应的风险始终存在,远程监控技术能够根据通过可穿戴设备和远程医疗平台看到的变化主动调整用药方案。随着患者决定在他们觉得方便和灵活的地方接受医疗保健服务,TDM 实践必将扩大市场并帮助改善总体治疗效果。
  • 人工智能和数据分析:由于人工智能和数据分析,TDM 市场正在发生巨大变化,在提高药物管理的精确度和有效性方面得到了优化。通过分析大量患者数据,AI 算法可以预测治疗模式和反应,从而有助于设计高度具体的治疗方案。通过使用高级分析软件,医疗保健提供者将能够为患者提供优化的给药方案以及对潜在不良反应的预测。此外,通过使用 AI,实验室结果解释将实现自动化,从而确保更快、更可靠的 TDM 流程。AI 和数据分析的应用可能会大力推动 TDM 市场的创新。
  • 专注于药物基因组学:事实上,过去几年来,药物基因组学的发展一直在影响 TDM 市场,因为它以一种非常差异化和有效的方式应用药物。通过确定药物代谢或药物反应中的遗传差异,可以决定适当的剂量或疗法,从而最大限度地减少副作用,同时最大限度地提高疗效。这种与 TDM 的整合支持医疗保健提供者在确定基因图谱的指导下做出决策,以便治疗、诊断或预防措施能够带来最佳结果。随着人们对药物基因组学的认识不断提高,药物基因组学测试越来越容易获得,其与 TDM 的结合将会增加,从而促进市场增长并确保有效改善对患者的护理。

治疗药物监测市场机会

  • 即时检测:即时检测正在通过提供即时的现场检测功能来改变治疗药物监测市场,从而改善对患者的护理。即时检测使医疗保健提供者能够在极短的时间内测量药物水平并监测治疗反应,以支持及时的临床决策,而无需进行集中实验室检测。对于高复杂度的药物,这种即时性在优化剂量并最大限度地减少副作用方面无疑是无价的。随着技术的进步,便携式用户友好型 TDM 设备的开发有望显著增加门诊和远程环境中的访问量。分散式医疗保健是一种日益增长的趋势,有利于 TDM 中的即时检测,因为它推动了市场的发展。
  • TDM 与数字健康技术的结合:TDM 与数字健康技术的结合对于通过提高药物依从性和监测来彻底改变患者护理至关重要。通过移动应用程序和远程医疗服务,可以在正确的时间收集和分析数据,从而根据患者独有的信息为医疗服务提供者提供及时输入,以立即调整治疗计划。TDM 与数字健康技术相结合,改善了患者与提供者之间的沟通,从而实现了更加个性化和主动的药物治疗管理。除此之外,在可穿戴设备的帮助下,可以在研究 TDM 疗效的同时监测患者的生命体征和药物反应。数字健康和 TDM 的这种协同作用将大大推动创新、优化患者治疗效果并增加获得有效药物管理的机会。
  • 新兴市场:近年来,新兴市场也为 TDM 市场带来了良好的增长机会,医疗保健投资不断增加,个性化医疗概念的意识也不断增强。随着各地区仍在加强其医疗基础设施并利用高度先进的诊断技术,TDM 服务具有巨大的增长空间。目前,慢性病患病率不断上升,制药行业不断发展,对有效药物监测的需求不断增长。进入这些市场的公司可以利用对个性化治疗管理方法的新需求,并与当地医疗保健提供商合作,进一步加强 TDM 的实施,确保患者获得良好的治疗效果。

 

治疗药物监测市场区域洞察

Insight Partners 的分析师已详尽解释了预测期内影响治疗药物监测市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的治疗药物监测市场细分和地理位置。

Therapeutic Drug Monitoring Market
  • 获取治疗药物监测市场的区域特定数据

治疗药物监测市场报告范围

报告属性细节
2024 年的市场规模XX 百万美元
2031 年市场规模XX 百万美元
全球复合年增长率(2024 - 2031)9.0%
史料2021-2023
预测期2025-2031
涵盖的领域按产品
  • 设备和耗材
按技术分类
  • 免疫测定
  • 色谱质谱法
  • 放射免疫分析
  • 其他的
按药物类别
  • 抗生素药物
  • 抗癫痫药物
  • 抗心律失常药物
  • 支气管扩张药
  • 免疫抑制药物
  • 精神活性药物
  • 抗癌药物
  • 其他药物
按最终用户
  • 医院实验室
  • 私人实验室
  • 其他实验室
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 雅培实验室
  • 安捷伦科技公司
  • Bio-Rad 实验室公司
  • 生物梅里埃公司
  • Bühlmann 实验室股份公司
  • 丹纳赫公司
  • F. 霍夫曼-罗氏有限公司
  • 朗道实验室有限公司
  • 西门子医疗

 

治疗药物监测市场参与者密度:了解其对业务动态的影响

治疗药物监测市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在治疗药物监测市场运营的主要公司有:

  1. 雅培实验室
  2. 安捷伦科技公司
  3. Bio-Rad 实验室公司
  4. 生物梅里埃公司
  5. Bühlmann 实验室股份公司

免责声明上面列出的公司没有按照任何特定顺序排列。


Therapeutic Drug Monitoring Market

 

  • 了解治疗药物监测市场的主要参与者概况

 

 

主要卖点

 

  • 全面覆盖:报告全面涵盖了治疗药物监测市场的产品、服务、类型和最终用户的分析,提供了整体概况。
  • 专家分析:报告基于对行业专家和分析师的深入了解而编写。
  • 最新信息:该报告涵盖了最新信息和数据趋势,确保了其与业务的相关性。
  • 定制选项:此报告可以定制以满足特定客户要求并恰当地适应业务策略。

因此,治疗药物监测市场研究报告有助于引领解读和了解行业情景和增长前景。尽管可能存在一些合理的担忧,但本报告的总体优势往往大于劣势。

  • 历史分析(2 年)、基准年、预测(7 年)及复合年增长率
  • PEST 和 SWOT 分析
  • 市场规模价值/数量 - 全球、区域、国家
  • 行业和竞争格局
  • Excel 数据集
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

常见问题


Which segment accounts for highest revenue by product in 2023?

Consumables segment, by product, dominated the market in 2023.

Which region dominated the Therapeutic Drug Monitoring market in 2023?

North America region dominated the Therapeutic Drug Monitoring market in 2023.

What are the factor that act as a opportunity for market growth?

Point-of-Care Testing act as a opportunity for growth of the market in forecast period.

What is the expected CAGR of the Therapeutic Drug Monitoring Market ?

The Therapeutic Drug Monitoring Market is estimated to witness a CAGR of 9.0% from 2023 to 2031

What are the driving factors impacting the Therapeutic Drug Monitoring market?

The major factors driving the Therapeutic Drug Monitoring market are:

1. Rising Prevalence of Chronic Diseases.

2.Growth in Personalized Medicine

Which are some of the players operating in the Therapeutic Drug Monitoring market?

Players operating in the market are Abbott Laboratories, Agilent Technologies, Inc., Bio-Rad Laboratories, bioMerieux SA, Bühlmann Laboratories AG, Danaher Corporation, F. Hoffmann-La Roche Ltd, and Randox Laboratories Ltd.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. Abbott Laboratories
2. Agilent Technologies, Inc.
3. Bio-Rad Laboratories Inc.
4. bioMerieux SA
5. Bühlmann Laboratories AG
6. Danaher Corporation
7. F. Hoffmann-La Roche Ltd
8. Randox Laboratories Ltd.
9. Siemens Healthineers
10. Thermo Fisher Scientific
therapeutic-drug-monitoring-market-cagr

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.